Log In
Discover
Assets
Jobs
Behance
Pro
Hire Freelancers
Download on the App Store
Get it on Google Play
English
Čeština
Dansk
Deutsch
Español
Français
Italiano
Nederlands
Norsk
Polski
Português
Pусский
Suomi
Svenska
Türkçe
日本語
한국어
中文(简体)
中文(繁體)
About
Blog
TOU
Privacy
Community
Help
Do not sell or share my personal information
Sign Up
Skip to Main Content
Skip to Footer
Behance
Behance
Navigate to behance.net
Explore
Assets
Jobs
Behance
Pro
Hire Freelancers
search
magnifying glass
Sort & filter all:
Projects
Images
People
Assets
People to Hire
Cancel
search
magnifying glass
View your notifications within Behance.
View your notifications within Behance.
Log In
Sign Up
search
magnifying glass
Adobe, Inc.
Adobe, Inc.
Navigate to adobe.com
Follow
Unfollow
Follow
Following
Message
Tools
InDesign
Photoshop
Tools
Add to Moodboard
Save
Share & Embed This Project
Share
Appreciate
Appreciate
Follow
Following
Unfollow
Follow
Unfollow
ALIMTA Paramount Trial leave behind
Joshua Sukosd
•
Follow
Following
Unfollow
ALIMTA Paramount Trial leave behind
Front cover
Inside flap, Back and Front covers
Inside spreads
Folding schematic
Join Behance
Sign up
or
Sign in
to view personalized recommendations, follow creatives, and more.
Sign Up With Email
Sign Up
or
Join Behance
Sign up
or
Sign in
to view personalized recommendations, follow creatives, and more.
Sign Up With Email
Sign Up
or
ALIMTA Paramount Trial leave behind
5
573
0
Published:
September 17th 2013
Joshua Sukosd
Follow
Following
Unfollow
Owner
Joshua Sukosd
Knoxville, TN, USA
Follow
Following
Unfollow
Message
ALIMTA Paramount Trial leave behind
This tri-fold was meant to be left with health care professionals so they would have one go-to source for all data pretaining to the extensive Pa
Read More
5
573
0
Published:
September 17th 2013
Tools
InDesign
Photoshop
Creative Fields
Art Direction
Graphic Design
ALIMTA
Pharmaceuticals
healthcare
Health Care Professionals
HCP
print
design
Layout
Production
Eli Lilly
Lilly
Lilly Oncology
Oncology
NSCLC
Treatment
Copyright Info
Attribution, Non-commercial, Share Alike
Read More
Report